As reported by IPWatchdog, Moderna is facing lawsuits in the United States from biotech firms, Arbutus Biopharma Corporation and Genevant Sciences GmbH.
Both companies allege that Moderna has infringed six of their U.S. patents relating to lipid nanoparticle (“LNP”) delivery technology. LNP delivery systems are crucial for mRNA therapies like Moderna’s COVID-19 vaccine by allowing treatments to bypass the human immune system without being destroyed.
Moderna has reportedly denied all allegations and vowed to vigorously defend itself against the claims made against it in court.
The plaintiffs in this action are seeking compensation, rather than an injunction, which is typically sought in such actions. If infringement is found, compensation through damages would likely be assessed through a “reasonable royalty”.
We are proud to share Goodmans has won Leading IP Law Firm - IP Patents at the Lexology Awards: North America 2024. These awards celebrate outstanding achievements and world class client…
A Yamaha patent application has been published for a new design of an augmented reality (AR) motorcycle helmet. The design introduces transparent lenses, which aim to combine the power of the AR…
Bad Bunny has reportedly sued a concertgoer for uploading extensive footage of his Utah concert to YouTube. The legal action, filed in California, marks a rare escalation in disputes typically…
The Delhi High Court reportedly had its initial hearing of Rupa Gujral and Ors v. Daryaganj Hospitality Private Limited and Ors in early 2024. The plaintiff, a famous restaurant chain, Moti Mahal…
Kim Kardashian and her interior design firm, Clements Design, are reportedly being sued by the Judd Foundation for promoting “cheap knockoffs” of one of Judd’s most renowned designs, a dining table…
French soccer star, Kylian Mbappé, has sought trademark protection over a logo depicting his iconic goal celebration. The logo is a black and white image of Mbappé standing with his hands tucked…
